FR3027M - Dérivés de sulfonanilide. - Google Patents

Dérivés de sulfonanilide.

Info

Publication number
FR3027M
FR3027M FR932206A FR932206A FR3027M FR 3027 M FR3027 M FR 3027M FR 932206 A FR932206 A FR 932206A FR 932206 A FR932206 A FR 932206A FR 3027 M FR3027 M FR 3027M
Authority
FR
France
Prior art keywords
sulfonanilide derivatives
sulfonanilide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR932206A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Application granted granted Critical
Publication of FR3027M publication Critical patent/FR3027M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR932206A 1962-01-24 1963-04-22 Dérivés de sulfonanilide. Active FR3027M (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16849862A 1962-01-24 1962-01-24
US24459762A 1962-12-14 1962-12-14
FR922364 1963-01-23
US38550464A 1964-07-27 1964-07-27
US439086A US3341584A (en) 1962-01-24 1965-03-11 Anilides

Publications (1)

Publication Number Publication Date
FR3027M true FR3027M (fr) 1964-12-28

Family

ID=27496795

Family Applications (4)

Application Number Title Priority Date Filing Date
FR148D Active FR148F (fr) 1962-01-24
FR1599658D Expired FR1599658A (fr) 1962-01-24 1963-01-23
FR932206A Active FR3027M (fr) 1962-01-24 1963-04-22 Dérivés de sulfonanilide.
FR19770A Expired FR95660E (fr) 1962-01-24 1965-06-05 Procédé de préparation de dérivés de sulfonanilides.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR148D Active FR148F (fr) 1962-01-24
FR1599658D Expired FR1599658A (fr) 1962-01-24 1963-01-23

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR19770A Expired FR95660E (fr) 1962-01-24 1965-06-05 Procédé de préparation de dérivés de sulfonanilides.

Country Status (9)

Country Link
US (1) US3341584A (fr)
BR (1) BR6346374D0 (fr)
CH (1) CH475962A (fr)
DE (1) DE1493955B2 (fr)
DK (1) DK122662B (fr)
FR (4) FR1599658A (fr)
GB (1) GB993584A (fr)
NL (1) NL139523B (fr)
SE (1) SE334368B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759993A (en) * 1971-09-27 1973-09-18 Riker Laboratories Inc Fluoromethanesulfonic acid derivatives
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
US3968242A (en) * 1974-08-26 1976-07-06 Mead Johnson & Company Sulfonamidoaminopropiophenone interceptive process
US3979514A (en) * 1974-08-26 1976-09-07 Mead Johnson & Company Process for interrupting pregnancy with sulfonamidoaminophene interceptive agents
GB1482099A (en) * 1974-12-11 1977-08-03 Wyeth John & Brother Ltd Sulphonamido derivatives
US3966770A (en) * 1975-03-25 1976-06-29 Smithkline Corporation 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
US4044150A (en) * 1976-06-18 1977-08-23 Mead Johnson & Company Antihypertensive 4'-[1-hydroxy-2-[(1-phenoxy ethyl)-amino]ethyl]methanesulfonanilide and salts thereof and therapeutic use
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
GB2077102A (en) * 1980-06-09 1981-12-16 Bristol Myers Co Ophthalmic compositions
US4404224A (en) * 1981-12-02 1983-09-13 American Cyanamid Company Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals
US4618624A (en) * 1981-12-02 1986-10-21 American Cyanamid Company 3-amino-4-hydroxy(or alkoxy)phenethanolamine derivatives and pharmacologically-acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm-blooded animals
US4540581A (en) * 1984-01-31 1985-09-10 Bristol-Myers Company Topical nonsteroidal anti-inflammatory compositions and uses
FR2541999B1 (fr) * 1983-03-04 1986-09-19 Bristol Myers Co Phenethanolamines et leurs utilisations
CA1237079A (fr) * 1983-05-23 1988-05-24 Arthur Simon Protocole antiarythmie
US5089526A (en) * 1983-05-23 1992-02-18 Bristol-Myers Company Antiarrhythmic class III process
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4507320A (en) * 1983-12-07 1985-03-26 Smithkline Beckman Corporation Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine
US4574129A (en) * 1984-01-31 1986-03-04 Bristol-Myers Company Topical nonsteroidal anti-inflammatory methods
US5155268A (en) * 1984-05-04 1992-10-13 The Upjohn Company Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4920116A (en) * 1985-06-28 1990-04-24 Schering A.G. N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4(methylsulfonylamino)benzamides
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
GB8707120D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US4857651A (en) * 1987-07-29 1989-08-15 American Cyanamid Company α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof
PH25458A (en) * 1987-08-24 1991-07-01 Eisai Co Ltd Piperidine derivatives, therapeutic, preventive agents
GB8909273D0 (en) * 1989-04-24 1989-06-07 Glaxo Group Ltd Chemical compounds
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
US5360822A (en) * 1990-02-07 1994-11-01 Nippon Shinyaku Co. Ltd. Sulfonanilide derivatives and medicine
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
ATE226988T1 (de) * 1992-08-26 2002-11-15 Procter & Gamble Papiermachervorrichtung mit semi-kontinuierlichem muster
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
DE10104369A1 (de) * 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
US6660772B2 (en) 2001-02-01 2003-12-09 Boehringer Ingelheim Pharma Kg Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
CN1812983A (zh) 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
KR20070104942A (ko) * 2005-02-21 2007-10-29 론자 아게 거울상적으로 순수한 1-치환-3-아미노알코올의 제조 방법
EP1948599A1 (fr) 2005-11-08 2008-07-30 Ranbaxy Laboratories Limited Procede de preparation de sel hemicalcique d acide (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoique
KR101479048B1 (ko) 2007-01-31 2015-01-05 도레이 카부시키가이샤 벤질아민 유도체 또는 그 약학적으로 허용되는 산부가염, 및 그 의약 용도
CN102112122B (zh) 2008-07-31 2013-04-24 东丽株式会社 含有苯甲胺衍生物或其药学上允许的酸加成盐的糖尿病、肥胖症、异常脂肪血症或代谢综合征的治疗剂或预防剂
BRPI0919920A2 (pt) * 2008-10-22 2016-02-16 Acucela Inc compostos para tratamento de doenças e desordens oftálmicas
US10793519B2 (en) 2018-05-02 2020-10-06 Academic Pharmaceuticals Incorporated Ultra short acting anti-arrhythmic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH364248A (de) * 1957-12-24 1962-09-15 Geigy Ag J R Verfahren zur Herstellung neuer Aminobenzoesäure-Derivate

Also Published As

Publication number Publication date
DK122662B (da) 1972-03-27
SE334368B (fr) 1971-04-26
FR95660E (fr) 1971-04-16
FR1599658A (fr) 1970-07-20
US3341584A (en) 1967-09-12
DE1493955A1 (de) 1971-08-19
DE1493955B2 (de) 1976-11-18
BR6346374D0 (pt) 1973-05-24
FR148F (fr)
GB993584A (fr)
CH475962A (de) 1969-07-31
NL139523B (nl) 1973-08-15

Similar Documents

Publication Publication Date Title
FR3027M (fr) Dérivés de sulfonanilide.
NL141771B (nl) Luier.
FR2973M (fr) Alpha-aminocétone.
BE622809A (fr) Dérivés de thiaxanthène.
FR3655M (fr) Dérivés de la thyronine.
DK112125B (da) Falstagsten.
DK105974C (da) Lastpallemagasin.
FR2930M (fr) Dérivés du diméthyldihydroanthracene.
NL143659B (nl) Fluidum-en-afsluiting.
FR3102M (fr) Dérivés de benzamide.
FR2592M (fr) Phénylbicyclononanes substitués.
FR3088M (fr) 2-oxo-tétrahydroquinoléines substituées.
FR3546M (fr) Azabenzocycloalcane-n-carboxamidines.
OA01221A (fr) Polythioformaldéhydes.
FR3097M (fr) Dérivés de phényl-dioxaborane substitué.
FR1850M (fr) Dérivés de la phénylalanine.
FR2728M (fr) Dérivés de 4-thiazolidinones.
FR2894M (fr) Phénylalcanolamine.
DK103099C (da) Plov.
FR1823M (fr) Dérivés de la cynarine.
FR2936M (fr) Dérivés de la pipérazine.
BE605974R (fr) Dérivés de benzothiadiazine.
FR1339M (fr) Dérivés de la dibenzazocine.
FR1386851A (fr) Dérivés de dodécahydro-1, 4, 7, 9b-tétrazophénalènes
FR2593M (fr) Dérivés du phénylbicyclononane.